- 1、本文档共9页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
- 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
- 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们。
- 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
- 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
孟鲁司特治疗小儿轻度持续哮喘疗效分析
孟鲁司特治疗小儿轻度持续哮喘疗效分析
【摘要】目的 探讨孟鲁司特治疗小儿轻度持续哮喘的临床疗效。方法 选取我院2009年1月―2011年1月期间收治的150例小儿轻度持续性哮喘患者,随机分为对照组75例,观察组75例。对照组患者给予糖皮质激素吸入治疗,观察组患者在给予糖皮质激素吸入治疗的基础上,同时服用孟鲁司特。两组治疗3个月后,比较两组患者的临床疗效,并将临床疗效结果进行统计学分析。结果 观察组患者临床疗效优42例,临床疗效良28例,临床疗效中5例,临床疗效差0例,临床疗效优良率93.33%;对照组临床疗效优21例,临床疗效良22例,临床疗效中30例,临床疗效差2例,临床疗效优良率57.33%。两组患者在临床疗效优良率上有显著性差异,(x2=34.87 ,p<0.05),有统计学意义。结论 孟鲁司特在治疗小儿轻度持续哮喘上具有理想的临床疗效,值得临床推广使用。
【关键词】孟鲁司特 小儿轻度持续哮喘 临床疗效
中图分类号:R725 文献标识码:B 文章编号:1005-0515(2012)2-011-02
Efficacy of montelukast treatment of children with mild persistent asthma
ZENG Zhao qin
(Weiyuan County, Sichuan Province Maternal and Child Health Hospital,, Neijiang 642 450)
【Abstract】Objective To investigate the clinical efficacy of montelukast treatment in children with mild persistent asthma. Methods 150 cases of children with mild persistent asthma patients admitted to hospital in January 2009 -2011 January, 75 cases were randomly divided into control group and observation group of 75 cases. The control group were treated with inhaled corticosteroids treatment, observation group were given on the basis of the treatment of inhaled corticosteroids, while taking montelukast. The two groups were compared two groups after 3 months of treatment, clinical efficacy, and clinical efficacy results were analyzed statistically. Results the clinical efficacy of the observation group were excellent in 42 cases, the clinical efficacy of good 28 cases, 5 cases of clinical efficacy, clinical efficacy is poor in 0 cases, excellent clinical efficacy rate was 93.33%; the clinical efficacy of the control group were excellent in 21 cases, the clinical efficacy of good in 22 cases, 30 cases of clinical efficacy, clinical efficacy difference between the two cases, excellent clinical efficacy rate of 57.33%. Two groups of patients in x2 = 34.87, excellent clinical efficacy rate, a significant difference (P 0.05) was statistically significant. Conclusion: The clinical efficacy of montelukast in the treatment of c
文档评论(0)